NQO1 and chronic obstructive pulmonary disease: Meanwhile, Dex and luteolin reversed the inhibiting effects of CS on the expressions of NQO1 and HO1 in COPD model mice (Figure 2J,K, p < .001, p < .05, and p < .001 for NQO1, p < .001 for HO1).